These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15908975)

  • 1. Rethinking the use of voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients.
    Brown J; Freeman BB
    Bone Marrow Transplant; 2005 Jul; 36(2):177. PubMed ID: 15908975
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis.
    Siwek GT; Pfaller MA; Polgreen PM; Cobb S; Hoth P; Magalheas-Silverman M; Diekema DJ
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):209-12. PubMed ID: 16626917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Berge M; Guillemain R; Boussaud V; Pham MH; Chevalier P; Batisse A; Amrein C; Dannaoui E; Loriot MA; Lillo-Le Louet A; Billaud EM
    Transpl Infect Dis; 2009 Jun; 11(3):211-9. PubMed ID: 19302272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients.
    Trifilio S; Ortiz R; Pennick G; Verma A; Pi J; Stosor V; Zembower T; Mehta J
    Bone Marrow Transplant; 2005 Mar; 35(5):509-13. PubMed ID: 15654347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosing voriconazole in an obese patient.
    Dickmeyer NJ; Kiel PJ
    Clin Infect Dis; 2011 Oct; 53(7):745. PubMed ID: 21846833
    [No Abstract]   [Full Text] [Related]  

  • 6. Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole.
    Trifilio S; Singhal S; Williams S; Frankfurt O; Gordon L; Evens A; Winter J; Tallman M; Pi J; Mehta J
    Bone Marrow Transplant; 2007 Sep; 40(5):451-6. PubMed ID: 17589527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenation.
    Brüggemann RJ; Antonius T; Heijst Av; Hoogerbrugge PM; Burger DM; Warris A
    Ther Drug Monit; 2008 Dec; 30(6):643-6. PubMed ID: 19057370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
    Marty FM; Lowry CM; Cutler CS; Campbell BJ; Fiumara K; Baden LR; Antin JH
    Biol Blood Marrow Transplant; 2006 May; 12(5):552-9. PubMed ID: 16635790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical application of voriconazole concentrations in the treatment of invasive aspergillosis.
    Howard A; Hoffman J; Sheth A
    Ann Pharmacother; 2008 Dec; 42(12):1859-64. PubMed ID: 19017830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and safety of 14 days intravenous voriconazole in allogeneic haematopoietic stem cell transplant recipients.
    Brüggemann RJ; Blijlevens NM; Burger DM; Franke B; Troke PF; Donnelly JP
    J Antimicrob Chemother; 2010 Jan; 65(1):107-13. PubMed ID: 19933691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic interaction between voriconazole and ciclosporin A following allogeneic bone marrow transplantation.
    Groll AH; Kolve H; Ehlert K; Paulussen M; Vormoor J
    J Antimicrob Chemother; 2004 Jan; 53(1):113-4. PubMed ID: 14657088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients.
    Mori T; Aisa Y; Kato J; Nakamura Y; Ikeda Y; Okamoto S
    Bone Marrow Transplant; 2009 Sep; 44(6):371-4. PubMed ID: 19270729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of voriconazole.
    Levêque D; Nivoix Y; Jehl F; Herbrecht R
    Int J Antimicrob Agents; 2006 Apr; 27(4):274-84. PubMed ID: 16563707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of oral voriconazole in patients with cystic fibrosis.
    Clifton IJ; Whitaker P; Metcalfe R; Phillip M; Shaw N; Conway SP; Peckham DG
    J Antimicrob Chemother; 2011 Oct; 66(10):2438-40. PubMed ID: 21791443
    [No Abstract]   [Full Text] [Related]  

  • 15. Voriconazole-associated severe hyponatremia.
    Kim KH; Lee S; Lee S; Yun NR; Kim NJ; Yu KS; Jang IJ; Park WB; Oh MD
    Med Mycol; 2012 Jan; 50(1):103-5. PubMed ID: 21671829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic drug monitoring of voriconazole in children.
    Chen J; Chan C; Colantonio D; Seto W
    Ther Drug Monit; 2012 Feb; 34(1):77-84. PubMed ID: 22210097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Update on voriconazole].
    Dtsch Med Wochenschr; 2003 Aug; 128(33):1738. PubMed ID: 12968630
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral voriconazole dose in children: one size does not fit all.
    Goutelle S; Larcher R; Padoin C; Mialou V; Bleyzac N
    Clin Infect Dis; 2010 Oct; 51(7):870; author reply 871. PubMed ID: 20809842
    [No Abstract]   [Full Text] [Related]  

  • 19. Voriconazole serum concentrations in prophylactically treated acute myelogenous leukaemia patients.
    Rüping MJ; Müller C; Vehreschild JJ; Böhme A; Mousset S; Harnischmacher U; Frommolt P; Wassmer G; Drzisga I; Hallek M; Cornely OA
    Mycoses; 2011 May; 54(3):230-3. PubMed ID: 19889174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hallucinations during voriconazole therapy: who is at higher risk and could benefit from therapeutic drug monitoring?
    Pea F; Viale P
    Ther Drug Monit; 2009 Feb; 31(1):135-6. PubMed ID: 19077926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.